ECHO-Chicago: Childhood Obesity-Spring 2018
Target Audience
Learning Objectives
At the conclusion of this activity, participatants will be able to:
- Identify risk factors to determine which children should be screened and treated for common comorbidities of obesity, including hyperlipidemia, hypertension, and impaired glucose metabolism;
- Describe common psychosocial problems associated with childhood obesity and methods of treatment;
- Determine approaches to counseling patients and families on lifestyle and behavioral changes to combat obesity that are feasible within the primary care medical home;
- Recognize secondary causes of obesity and identify pharmacological treatments;
- Recognize individual and family, social, economic, and environmental barriers to change.
- 12.00 AMA PRA Category 1 Credit™
- 12.00 Participation
For more information about ECHO Chicago, visit us here.
COURSE FACULTY
Associate Chair for Clinical Services
Section Chief of Academic Pediatrics
Associate Professor of Pediatrics
Comer Children's Hospital
Jack H. Medalle Professor & Chair, Family Medicine
Case Western Reserve University
University Hospitals of Cleveland
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.